Hovione Launches ASD-HIPROS

The Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation

Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Bilim Pharmaceuticals, H&T Presspart and Hovione Technology unveil collaboration for new asthma product: Ventofor Combi Fix delivered by PowdAir Plus

Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

Effective May 1st, 2020

Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel

Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.

Hovione celebrates its 60th Anniversary in Cork

Loughbeg, Co. Cork. Thursday, September 5th, 2019: Hovione is celebrating its 60th Anniversary today in its site in Cork.

Hovione issues $50 million bond

Hovione has issued a bond of $50 million US dollars maturing in 2033.

Hovione increases production capacity

‘One Site Shop’ expands to respond to growing demands

Hovione reports on recent capacity expansion and future plans to support growth

Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.

Compliance at Hovione - Annual Inspection Review

Hovione announced today that in the last year their manufacturing facilities were the object of eight inspections, performed by different Health Authorities.